ClearPoint Neuro, Inc.
CLPT
$12.97
-$0.14-1.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.44% | -32.42% | -45.34% | -16.61% | -3.43% |
| Total Depreciation and Amortization | -13.94% | 35.21% | -29.54% | 11.08% | 17.02% |
| Total Amortization of Deferred Charges | 77.27% | 50.00% | -- | -100.00% | 57.14% |
| Total Other Non-Cash Items | 22.90% | 70.10% | 56.48% | 0.84% | -6.35% |
| Change in Net Operating Assets | -102.58% | 214.53% | -69.05% | 57.95% | 149.36% |
| Cash from Operations | -160.30% | 4.35% | -60.73% | -6.33% | 33.24% |
| Capital Expenditure | -1,558.33% | -- | -- | -1,152.38% | 94.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,558.33% | -- | -- | -39.89% | 94.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1,150.69% | -99.87% | -36.98% | -- |
| Repurchase of Common Stock | 100.00% | -178.13% | -764.24% | -127.03% | 32.97% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 19,885.63% | -108.48% | -76.13% | -10,956.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.55% | 1,269.62% | -163.19% | -22.21% | -431.20% |